Open Access Email this article to a friend

KRAS rs61764370 is associated with HER2-overexpressed and poorly-differentiated breast cancer in hormone replacement therapy users: a case control study

Jasmina-Ziva Cerne, Vida Stegel, Ksenija Gersak and Srdjan Novakovic*

BMC Cancer 2012, 12:105  doi:10.1186/1471-2407-12-105

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.
How can I ensure that I receive BMC Cancer's emails?